Corrigendum: Development and validation of nomogram models for predicting immune-related adverse events in recurrent and metastatic nasopharyngeal carcinoma patients treated with PD-L1 inhibitors - Liu, Mengyuan; Liu, Zheran; He, Shuangshuang; Pei, Yiyan; Xu, Shihong; Ge, Junyou; Qing, Yan; Wei, Youneng; Chen, Ye; Ai, Ping; Peng, Xingchen (Frontiers in Oncology, 2025)